BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35925422)

  • 1. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
    Hu H; Li M; Chen B; Guo C; Yang N
    Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.
    Guo C; Fu R; Zhou M; Wang S; Huang Y; Hu H; Zhao J; Gaskin F; Yang N; Fu SM
    J Autoimmun; 2019 Sep; 103():102286. PubMed ID: 31133359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
    Liu M; Li H; Yang R; Ji D; Xia X
    J Neuroinflammation; 2022 Oct; 19(1):262. PubMed ID: 36289519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis.
    Matoba K; Nagai Y; Sekiguchi K; Ohashi S; Mitsuyoshi E; Shimoda M; Tachibana T; Kawanami D; Yokota T; Utsunomiya K; Nishimura R
    Commun Biol; 2024 Apr; 7(1):402. PubMed ID: 38565675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
    Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
    Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
    Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
    Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
    Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
    Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
    Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
    Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
    Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
    [No Abstract]   [Full Text] [Related]  

  • 17. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
    Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
    Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
    Nakatani K; Asai O; Konishi N; Iwano M
    Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.